Chromhidrosis Treatment Market

Chromhidrosis is a rare condition characterized by the secretion of colored sweat. There are two types of glands such as apocrine and eccrine gland. Apocrine glands secrete a milky sweat that, once fragmented down by bacteria, is the main cause of body odor whereas Eccrine glands secrete an odorless, clear fluid that serves to regulate body temperature. In addition, Chromhidrosis can be caused by various agents such as coloring agents used as food additives and this is anticipated to increase the demand for Chromhidrosis Treatment. There are three types of Chromhidrosis which includes Apocrine chromhidrosis, True eccrine chromhidrosis, Pseudo-eccrine chromhidrosis. Eccrine chromhidrosis can occur almost any place on the body as these glands are distributed with varying density throughout the skin except for the ear canal, prepuce, glans penis, clitoris, and lips and this is expected to increase the demand for Chromhidrosis treatment.
Chromhidrosis Treatment Market contains market size and forecasts of Chromhidrosis Treatment in Global, including the following market information:
Global Chromhidrosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chromhidrosis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Apocrine Chromhidrosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chromhidrosis Treatment include Ipsen Pharma, Medytox, Revence Therapeutics, Inc. and ALLERGAN, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chromhidrosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chromhidrosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chromhidrosis Treatment Market Segment Percentages, by Type, 2021 (%)
Apocrine Chromhidrosis
Eccrine Chromhidrosis
Pseudochromhidrosis
Global Chromhidrosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chromhidrosis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals and Clinics
Specialty and Dermatology Clinics
Others
Global Chromhidrosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chromhidrosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chromhidrosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chromhidrosis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ipsen Pharma
Medytox
Revence Therapeutics, Inc.
ALLERGAN